Live feed07:00:00·115dPRReleasevia QuantisnowRezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor HyperinsulinismByQuantisnow·Wall Street's wire, on your screen.RZLT· Rezolute Inc.Health Care
